APOB and familial hyperaldosteronism: The molecular diagnosis was confirmed for 35 (30.7%) patients, who carried pathogenic or likely pathogenic variants in LDLR (32) and APOB (1), according to ACMG classification, and a GOF variant in PCSK9 (2) previously associated with FH.